Antiepileptic drugs in pregnancy and hemorrhagic disease of the newborn: An update

Aleksey Kazmin; Renee C. Wong; Mathew Sermer; Gideon Koren

Antiepileptic drugs in pregnancy and hemorrhagic disease of the newborn: An update

Aleksey Kazmin, Renee C. Wong, Mathew Sermer, Gideon Koren

Research output: Contribution to journal › Short survey › peer-review

10 Scopus citations

Abstract

QUESTION: What is the current evidence regarding the association between hemorrhagic disease of the newborn and maternal use of hepatic enzyme-inducing antiepileptic drugs (eg, carbamazepine, phenobarbitone, topiramate)? ANSWER: Women with epilepsy who take enzyme-inducing antiepileptic drugs should be advised that there is no adequate evidence to support or refute taking vitamin K in late pregnancy to prevent bleeding complications in a newborn.

Original language	English
Pages (from-to)	1291-1292
Number of pages	2
Journal	Canadian Family Physician
Volume	56
Issue number	12
State	Published - Dec 2010
Externally published	Yes

Cite this

@article{6fde5b7ec86d4e028b1da281b19c1a74,

title = "Antiepileptic drugs in pregnancy and hemorrhagic disease of the newborn: An update",

abstract = "QUESTION: What is the current evidence regarding the association between hemorrhagic disease of the newborn and maternal use of hepatic enzyme-inducing antiepileptic drugs (eg, carbamazepine, phenobarbitone, topiramate)? ANSWER: Women with epilepsy who take enzyme-inducing antiepileptic drugs should be advised that there is no adequate evidence to support or refute taking vitamin K in late pregnancy to prevent bleeding complications in a newborn.",

author = "Aleksey Kazmin and Wong, \{Renee C.\} and Mathew Sermer and Gideon Koren",

year = "2010",

month = dec,

language = "אנגלית",

volume = "56",

pages = "1291--1292",

journal = "Canadian Family Physician",

issn = "0008-350X",

publisher = "College of Family Physicians of Canada",

number = "12",

}

TY - JOUR

T1 - Antiepileptic drugs in pregnancy and hemorrhagic disease of the newborn

T2 - An update

AU - Kazmin, Aleksey

AU - Wong, Renee C.

AU - Sermer, Mathew

AU - Koren, Gideon

PY - 2010/12

Y1 - 2010/12

N2 - QUESTION: What is the current evidence regarding the association between hemorrhagic disease of the newborn and maternal use of hepatic enzyme-inducing antiepileptic drugs (eg, carbamazepine, phenobarbitone, topiramate)? ANSWER: Women with epilepsy who take enzyme-inducing antiepileptic drugs should be advised that there is no adequate evidence to support or refute taking vitamin K in late pregnancy to prevent bleeding complications in a newborn.

AB - QUESTION: What is the current evidence regarding the association between hemorrhagic disease of the newborn and maternal use of hepatic enzyme-inducing antiepileptic drugs (eg, carbamazepine, phenobarbitone, topiramate)? ANSWER: Women with epilepsy who take enzyme-inducing antiepileptic drugs should be advised that there is no adequate evidence to support or refute taking vitamin K in late pregnancy to prevent bleeding complications in a newborn.

UR - https://www.scopus.com/pages/publications/78650440691

M3 - ???researchoutput.researchoutputtypes.contributiontojournal.shortsurvey???

C2 - 21156891

AN - SCOPUS:78650440691

SN - 0008-350X

VL - 56

SP - 1291

EP - 1292

JO - Canadian Family Physician

JF - Canadian Family Physician

IS - 12

ER -

Antiepileptic drugs in pregnancy and hemorrhagic disease of the newborn: An update

Abstract

Other files and links

Fingerprint

Cite this